AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comNOV 31 min read$INSP

Inspire: Q3 Earnings Snapshot

Inspire Medical Systems (INSP) reported a Q3 loss of $24.4M, or 84 cents per share, but adjusted earnings of 14 cents per share, beating estimates. Revenue was $206.7M, also topping forecasts. The company expects full-year earnings of $1.20-$1.40 per share and revenue of $850M-$860M.

Original reporting
finance.yahoo.com
Published Nov 3, 2026, 4:29 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 4:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Inspire: Q3 Earnings Snapshot — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$INSPBullishMed
01

Why it matters

Earnings beat on both EPS and revenue could trigger short‑term buying, but the loss per share remains high, limiting upside.

02

Market read

The earnings surprise offers a trading opportunity for INSP, with limited broader market impact.

03

What to watch

Guidance range of $1.20‑$1.40 per share suggests modest growth; market may price in slower upside.

Relevance 7/10Novelty 8/10Timing: after-hours

Background

Inspire Medical Systems (NASDAQ:INSP) provides devices for obstructive sleep apnea. The Q3 results were generated by Automated Insights using Zacks data.

Company-level read

Ticker impact

$INSPBullishHigh confidence
Context

Inspire Medical Systems reported Q3 loss of $24.4M and revenue of $206.7M, both beating analyst expectations.

Expected impact

likely modest upside as the beat may attract buying pressure

Evidence & confidence

The company posted a loss but beat EPS and revenue forecasts, which typically prompts short-term buying.

Market effects

Sector

Positive earnings surprise may lift other sleep‑apnea device makers.

Regional

Limited to US small‑cap healthcare sector.

Global

Low global relevance.

Counterpoint

What could challenge this read

Losses remain sizable; investors may stay cautious despite the beat.

Key entities

  • company
    Inspire Medical Systems Inc.

    Manufacturer of sleep‑apnea treatment devices.

Read at source← All news

StoryInspire Medical Systems reports Q3 2026 earnings beat and raises full‑year EPS guidance

Also covered by

2 outlets

Related articles

NOV 3
$INSPMedAI 8/10

Inspire (INSP) Q3 2026 Earnings Call Transcript

Inspire (INSP) reported Q3 2026 revenue of $206.7M, down 7.9% YoY but up 3% sequentially. The company expects stable coding framework in 2027 and a new code in 2028, with strong adoption of Inspire V. Operating loss was $28.7M, and adjusted EPS was $0.14. The company is investing in patient flow optimization and expanding market reach. According to the company, they remain confident in their path to growth.

finance.yahoo.com3 min
NOV 3
$INSPMed

Inspire Medical Systems Q3 Earnings Call Highlights

Inspire Medical Systems (INSP) reported Q3 earnings, estimating coding and reimbursement challenges reduced results by $30M and may impact 2026 results by $120M. The company expects revenue growth in Q4 and low-single-digit growth in 2027, citing stable coding and investments. Inspire highlighted a new CPT code for its Inspire V device and ongoing development of Inspire VI. Management discussed clinical evidence supporting their therapy and plans to invest in patient access and education.

finance.yahoo.com2 min
NOV 2
$INSPHighAI 8/10

Inspire Medical Q3 2026 slides: reimbursement clarity ahead, growth reset

Inspire Medical Systems reported Q3 2026 revenue of $206.7M, down 7.9% YoY but up 3.0% sequentially. The company cited reimbursement challenges as the primary headwind. Shares rose 1.83% in after-hours trading. Inspire highlighted its market position and long-term growth potential, despite near-term slowdowns. The company expects full-year 2026 revenue of $850M-$860M, down from 2025 levels.

investing.com3 min
NOV 2
$INSPMedAI 8/10

Inspire Medical Systems (NYSE:INSP) beats Q3 2026 sales expectations

Inspire Medical Systems reported Q3 2026 revenue of $206.7 million, exceeding estimates by 1.1%, and adjusted EPS of $0.14, beating estimates by 54.1%. The company reconfirmed its full-year revenue guidance of $855 million but raised adjusted EPS guidance to $1.30, a 4% increase. Operating margin declined to -13.9% from 4.3% year-on-year.

finance.yahoo.com3 min
NOV 2
$INSPMedAI 8/10

Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results

Inspire Medical Systems, Inc. (INSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results • Third quarter revenue of $206.7 million • Third quarter diluted EPS of $(0.84); adjusted diluted EPS of $0.14 • Third quarter operating cash flow of $46.4 million • AMA CPT® Editorial Pane

SEC EDGAR 8-K3 min